The Kinetics of Cyclosporine and Its Metabolites in Bone Marrow Transplant Patients

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1991 Sep 1

PMID 1777368

Citations 10

Authors

T L Schwinghammer

D Przepiorka

R Venkataramanan

C P Wang

G J Burckart

C S Rosenfeld

R K Shadduck

Affiliations

Soon will be listed here.

Abstract

1. The pharmacokinetics of cyclosporine (CsA) and the time course of CsA metabolites were studied in five bone marrow transplant patients after intravenous (i.v.) administration on two separate occasions and once after oral CsA administration. 2. Cyclosporine and cyclosporine metabolites were measured in whole blood by h.p.l.c. 3. Cyclosporine clearance after i.v. administration decreased from 3.9 +/- 1.7 ml min-1 kg-1 to 2.0 +/- 0.6 ml min-1 kg-1 after 14 days of treatment. The mean +/- s.d. absolute oral bioavailability of cyclosporine was 17 +/- 11%. 4. Hydroxylated CsA (M-17) was the major metabolite in blood. There were no significant differences in the mean metabolite/CsA AUC ratios between the first and second i.v. studies. 5. After oral administration, the metabolite to CsA AUC ratios were higher for most metabolites compared to those observed in the second i.v. study, suggesting a contribution of intestinal metabolism to the clearance of CsA.

Citing Articles

Inflammation Decreases Ciclosporin Metabolism in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Malnoe D, Bories M, Pierre-Jean M, Marchand T, Le Corre P J Clin Pharmacol. 2024; 65(3):328-339.

PMID: 39382849 PMC: 11867918. DOI: 10.1002/jcph.6141.

Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I.

McCune J, Bemer M Clin Pharmacokinet. 2015; 55(5):525-50.

PMID: 26563168 PMC: 4824666. DOI: 10.1007/s40262-015-0339-2.

Population pharmacokinetics of cyclosporine in transplant recipients.

Han K, Pillai V, Venkataramanan R AAPS J. 2013; 15(4):901-12.

PMID: 23775356 PMC: 3787227. DOI: 10.1208/s12248-013-9500-8.

Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction potential.

Gertz M, Cartwright C, Hobbs M, Kenworthy K, Rowland M, Houston J Pharm Res. 2012; 30(3):761-80.

PMID: 23179780 DOI: 10.1007/s11095-012-0918-y.

Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.

Wilhelm A, de Graaf P, I Veldkamp A, Janssen J, Huijgens P, Swart E Br J Clin Pharmacol. 2011; 73(4):553-63.

PMID: 21988410 PMC: 3376432. DOI: 10.1111/j.1365-2125.2011.04116.x.

References

Maurer G . Metabolism of cyclosporine. Transplant Proc. 1985; 17(4 Suppl 1):19-26. View

Maurer G, Lemaire M . Biotransformation and distribution in blood of cyclosporine and its metabolites. Transplant Proc. 1986; 18(6 Suppl 5):25-34. View

Atkinson K, BIGGS J, Britton K, Short R, Mrongovius R, Concannon A . Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction. Br J Haematol. 1984; 56(2):223-31. DOI: 10.1111/j.1365-2141.1984.tb03950.x. View

Keown P, Laupacis A, Carruthers G, Stawecki M, Koegler J, McKenzie F . Interaction between phenytoin and cyclosporine following organ transplantation. Transplantation. 1984; 38(3):304-6. View

Ptachcinski R, Venkataramanan R, Burckart G . Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinet. 1986; 11(2):107-32. DOI: 10.2165/00003088-198611020-00002. View

Augustine J, Zemaitis M . The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat. Drug Metab Dispos. 1986; 14(1):73-8. View

Zeevi A, Eiras G, Burckart G, Makowka L, Venkataramanan R, Wang C . Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells. Transplant Proc. 1988; 20(2 Suppl 2):115-21. PMC: 2965464. View

Zeevi A, Venkataramanan R, Burckart G, Wang C, Murase N, Van Thiel D . Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Hum Immunol. 1988; 21(2):143-53. DOI: 10.1016/0198-8859(88)90089-4. View

Freed B, Rosano T, LEMPERT N . In vitro immunosuppressive properties of cyclosporine metabolites. Transplantation. 1987; 43(1):123-7. DOI: 10.1097/00007890-198701000-00027. View

10.

Rosano T, Freed B, CERILLI J, LEMPERT N . Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients. Transplantation. 1986; 42(3):262-7. DOI: 10.1097/00007890-198609000-00007. View

11.

Wang C, Burckart G, Ptachcinski R, Venkataramanan R, Schwinghammer T, Hakala T . Cyclosporine metabolite concentrations in the blood of liver, heart, kidney, and bone marrow transplant patients. Transplant Proc. 1988; 20(2 Suppl 2):591-6. PMC: 2963197. View

12.

van der Heyden A, van Oers M, Cornelissen P, Yong S, Wilmink J, Schellekens P . The influence of cyclosporine A treatment on immune responsiveness in vitro and in vivo in kidney transplant recipients. Transplant Proc. 1988; 20(2 Suppl 2):190-5. PMC: 3000132. View

13.

Cole E, Cheung F, Wong P, Fung L, Skorecki K, Levy G . Toxic effects on renal cells in culture--a comparison of cyclosporin A and its metabolites. Transplant Proc. 1989; 21(1 Pt 1):943-5. View

14.

Rosenfeld C, Shadduck R, Przepiorka D, Mangan K, Colvin M . Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse. Blood. 1989; 74(3):1159-64. View

15.

Venkataramanan R, Habucky K, Burckart G, Ptachcinski R . Clinical pharmacokinetics in organ transplant patients. Clin Pharmacokinet. 1989; 16(3):134-61. DOI: 10.2165/00003088-198916030-00002. View

16.

Wallemacq P, Lhoest G, Latinne D, de Bruyere M . Isolation, characterization and in vitro activity of human cyclosporin A metabolites. Transplant Proc. 1989; 21(1 Pt 1):906-10. View

17.

Awni W, Kasiske B, Rao K . Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism. Clin Pharmacol Ther. 1989; 45(1):41-8. DOI: 10.1038/clpt.1989.7. View

18.

Burckart G, Starzl T, Venkataramanan R, Hashim H, Wong L, Wang P . Excretion of cyclosporine and its metabolites in human bile. Transplant Proc. 1986; 18(6 Suppl 5):46-9. PMC: 2903880. View

19.

Rosano T, Freed B, Pell M, LEMPERT N . Cyclosporine metabolites in human blood and renal tissue. Transplant Proc. 1986; 18(6 Suppl 5):35-40. View

20.

Pang K . Metabolite pharmacokinetics: the area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites. J Pharmacokinet Biopharm. 1981; 9(4):477-87. DOI: 10.1007/BF01060890. View